These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8867916)

  • 21. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of morphine analgesia by intracerebroventricular naloxonazine.
    Simone DA; Bodnar RJ; Portzline T; Pasternak GW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1721-7. PubMed ID: 3016762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
    Ko MC; Butelman ER; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 1998 May; 285(2):518-26. PubMed ID: 9580592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
    Negri L; Lattanzi R; Tabacco F; Melchiorri P
    Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
    Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
    J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
    Su YF; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a nanostructured dendrimer-naloxonazine complex on endogenous opioid peptides μ1 receptor-mediated post-ictal antinociception.
    Felippotti TT; do Carmo DR; Paim LL; Stradiotto NR; Bicalho Ude O; Parada CA; Grillo R; Fraceto LF; Coimbra NC
    Nanomedicine; 2011 Dec; 7(6):871-80. PubMed ID: 21419866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.
    Paronis CA; Bergman J
    J Pharmacol Exp Ther; 2011 Feb; 336(2):488-95. PubMed ID: 21051498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
    Dykstra LA; Gmerek DE; Winger G; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
    Butelman ER; France CP; Woods JH
    J Pharmacol Exp Ther; 1993 Jan; 264(1):145-51. PubMed ID: 8093721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
    Howell LL; Bergman J; Morse WH
    J Pharmacol Exp Ther; 1988 Apr; 245(1):364-72. PubMed ID: 2834543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.